Cytopath Laboratory

Haverford Healthcare Advisors advises Cytopath Laboratory on its Sale to AmeriPath

Haverford’s Client:
Cytopath Laboratory
West Palm Beach, FL
Other Party:
AmeriPath, Inc. (NASDAQ: PATH)
Haverford’s Role:
Sellside Advisor
Healthcare Segment:
Connect with Lead Advisor:
Christopher Jahnle

Contact us today

Let’s connect to see how we can work together to help your business succeed.
Skip to content